688163 赛伦生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.3424.0613.5138.61023.029
总资产报酬率 ROA (%)0.3363.9403.3798.18121.393
投入资产回报率 ROIC (%)0.3404.0083.4468.38722.219

边际利润分析
销售毛利率 (%)74.82678.05775.70983.77083.682
营业利润率 (%)16.50826.67024.18442.85542.268
息税前利润/营业总收入 (%)14.69625.08422.67240.96441.803
净利润/营业总收入 (%)14.66522.72320.39236.84936.648

收益指标分析
经营活动净收益/利润总额(%)47.986101.80188.00678.66097.011
价值变动净收益/利润总额(%)78.39110.22322.75621.667-0.896
营业外收支净额/利润总额(%)-1.477-2.806-1.252-0.843-0.378

偿债能力分析
流动比率 (X)74.94946.70037.97937.10414.050
速动比率 (X)71.04844.49536.18835.07511.263
资产负债率 (%)1.5342.1903.7783.8458.256
带息债务/全部投入资本 (%)0.2050.2270.3330.2940.712
股东权益/带息债务 (%)48,544.24143,849.60829,465.78033,387.04513,386.062
股东权益/负债合计 (%)6,417.9804,465.3532,547.0122,500.4961,111.266
利息保障倍数 (X)-9.350-29.206-18.689-26.735-137.029

营运能力分析
应收账款周转天数 (天)150.84054.77528.69717.84111.392
存货周转天数 (天)633.153370.449386.922660.221522.744